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Abstract: The Gram-negative Campylobacter jejuni is a major cause of foodborne gastroenteritis in
humans worldwide. The cytotoxic effects of Campylobacter have been mainly ascribed to the actions
of the cytolethal distending toxin (CDT): it is mandatory to put in evidence risk factors for sequela
development, such as reactive arthritis (ReA) and Guillain–Barré syndrome (GBS). Several researches
are directed to managing symptom severity and the possible onset of sequelae. We found for the
first time that rapamycin (RM) is able to largely inhibit the action of C. jejuni lysate CDT in U937
cells, and to partially avoid the activation of specific sub-lethal effects. In fact, we observed that
the ability of this drug to redirect lysosomal compartment, stimulate ER-remodeling (highlighted
by ER–lysosome and ER–mitochondria contacts), protect mitochondria network, and downregulate
CD317/tetherin, is an important component of membrane microdomains. In particular, lysosomes are
involved in the process of the reduction of intoxication, until the final step of lysosome exocytosis.
Our results indicate that rapamycin confers protection against C. jejuni bacterial lysate insults to
myeloid cells.
Keywords: Campylobacter jejuni; rapamycin; ER-remodeling; lysosome positioning and exocytosis;
CD317/tetherin
1. Introduction
The lysosome is the terminal component of the endocytic pathway, which possesses a series
of biological functions including endocytosis, exocytosis, macropinocytosis, plasma membrane
repair, defence against pathogens, cell death, signal transduction, and autophagy [1]. Autophagy
has been proposed to be a component of the innate immune response against several types of
intracellular microorganisms [2]. In physiological conditions, autophagosomes form and successfully
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fuse with lysosomes at baseline rates, underling the ability of autophagy to support normal
cellular functions. In the presence of an autophagic stimulus, the rate of autophagosome formation,
autophagosome–lysosome fusion, and lysosomal degradation increases, resulting in accelerated
degradation of autophagic substrates [3]. In fact, autophagy stands out as a key process for the lysosomal
degradation of cytosolic entities that is highly interconnected with several other biological functions.
Although in many cases autophagy contributes to cell death, it has a protective and pro-survival
function. Autophagy and apoptosis are two fundamental biological mechanisms that may cooperate
or be antagonistic, and both are involved in deciding the fate of cells in physiological or
pathological conditions.
The functional relationship between apoptosis (‘self-killing’) and autophagy (‘self-eating’) is
intricate. Under certain circumstances, autophagy constitutes a stress adaptation that avoids cell death
and suppresses apoptosis, whereas in others, it represents an alternative killing mechanism which is
activated when apoptosis cannot be executed [4,5]. It is essential to determine which mechanism has
to be activated as we try to either protect the cells from cell death, as in neurodegenerative diseases,
or induce cell death, as in cancer treatment [6]. Other studies linked autophagy to facilitating the
mitochondrial permeability transition: both apoptosis and autophagy could permit this process to
cause cell death [7]. Depending on the upstream signals and the different instances, cells activate
apoptosis or autophagy, or both, by combining or switching between them in a mutually exclusive
manner [8] It is difficult to predict if autophagy is positive or negative: it depends on what gets
degraded under different circumstances. Rapamycin, an antibiotic discovered as an anti-fungal agent
in the 1970s, is an efficient inhibitor of mammalian target of rapamycin (mTOR) resulting in autophagic
induction [9]. In mammals, mTOR is the central player in autophagy signaling. It is a serine/threonine
kinase which inhibits autophagy by controlling both translation and transcription of autophagy-related
(Atg) proteins, therefore interfering with the formation of autophagosomes. Recent studies showed
that mammalian target of rapamycin complex 1 (mTORC1) signaling acts with the ER stress response
and contributes to the cell fate decision [10–12].
Furthermore, the host cell plasma membrane is a central element in pathogen–host associations
with interaction at the cell surface leading to internalization, while intracellular membranes play a critical
role in subsequent pathogen trafficking. Ultimately, such pathogen–membrane lipid interactions work
coordinately to mediate cytotoxicity [13]. CD317/tetherin (also called tetherin, BST2 or HM1.24) is a lipid
raft-associated protein with several protective and deleterious roles. Despite its localization to lipid rafts,
CD317/tetherin is internalized via clathrin-dependent endocytosis [14]. Mature CD317/tetherin recycles
between the plasma membrane, endosomes, and trans-Golgi network (TGN) [15,16]. Regulation of
virus restriction and tumor aggressiveness are the most studied aspects of CD317/tetherin function,
where CD317/tetherin is expressed in airway and mucosal epithelia in response to viral infection [17].
Research has focused on the involvement of CD317/BST2 in cancer cells and cancer biology re-evaluation
of the overall role of CD317/tetherin in host protection, as it appears that CD317/tetherin has pleiotropic
effects in the host. In addition, it has been recently demonstrated [18] that BST2-mediated signaling
may be involved in the balance of apoptosis and autophagy: the latter is a process representing a
critical mechanism that regulates the fate of infected cells. CD317 might attach exosomes both to
the plasma membrane and to each other: it acts to inhibit the spread of certain enveloped viruses,
by cross-linking the virions and holding them together at the plasma membrane [19]. Edgar et al.
have demonstrated that tetherin might act in a similar manner on exosomal vesicles [20], decreasing
CD317’s ability to reduce the number of exosomes associated with the plasma membrane of HeLa cells,
with a concomitant increase in exosomes released into the medium.
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Campylobacter jejuni is the most common causative agent of foodborne infectious illnesses in
humans [21]. This Gram-negative bacterium is able to establish commensalism in several animal hosts
and promote human diarrheal disease, and C. jejuni-associated enterocolitis is typically linked with a
local acute inflammatory response that involves intestinal tissue damage [22].
C. jejuni, like several other Gram-negative bacteria, produces the cytolethal distending toxin
(CDT), which is an important virulence factor that has been characterized in detail [23–29]. CDT is
encoded by the cdtABC operon and has three components: CdtA, CdtB, and CdtC. CdtB is a DNAse I
that leads to DNA double-strand breakage in the nucleus, resulting in cell cycle arrest at the G2/M
phase, thereby inducing cell distension [30], target-cell death, and/or autophagy. CdtA and CdtC
assemble a tripartite complex with CdtB, and act as carriers for delivering CdtB into the cell [31].
C. jejuni CDT is released through outer membrane vesicles [32], which fuse with the host plasma
membrane via lipid rafts [26], leading to its internalization within the host cells [33]. CdtA and CdtC
subunits are only able to bind these cholesterol-rich microdomains on the cytoplasmic membrane,
allowing the delivery of the active subunit to cells [34–36]. Recently, the carcinogenic potential of
C. jejuni and the key role of CDT in this process have been demonstrated [37]. CDT is also produced by
S. typhi [38,39], in addition to Escherichia coli [23] and other causative agents of chronic infection, such as
Haemophilus ducreyi [26], Shigella dysenteriae [28], Actinobacillus actinomycetemcomitans [40], Helicobacter
hepaticus [27], and other species [41,42]. The damage to the host cells can be mediated either [39,43]: (1)
directly by (a) enzymatic attack, (b) DNA damage, or (c) by affecting DNA damage repair mechanisms,
or (2) indirectly, by (a) provoking a chronic inflammatory reaction, or (b) producing free radicals.
These changes might be associated with carcinogenesis and might stimulate cellular aberrations,
modify the immune response, or inhibit normal cell controls. Several studies have indicated that pRb
proteins exhibit tumor suppressor activities, and play a central role in cell cycle regulation. In fact,
recent data [44] have shown that this protein, although owing to its role in G1/S cell cycle checkpoint,
participates in many other cellular functions, including, counterintuitively, the negative regulation of
apoptosis cell-cycle activation, and apoptotic inhibition can be directly related to autophagy induction.
We have previously demonstrated that lysates containing CDT from all strains are able to induce
endoplasmic reticulum (ER) stress in monocytes, suggesting that ER stress was not associated with
CDT, but with other C. jejuni virulence factors [45]. In the present study, ER was investigated in U937
cells treated by lysates and with the addition of rapamycin (RM), in association with lysosomes, in the
mechanisms of escape from lysate intoxication. U937 cells were adopted secondarily to monocytes [45].
In fact, as they are known to be effective producers of both pro- and anti-inflammatory cytokines,
monocytes play a major role in innate immunity and in non-specific host response against both
exogenous pathogens—primarily by phagocytosis—and endogenous substances created by tissue
damage [46]. Furthermore, other researchers [47–49] adopted U937 monocytic cells as a model to study
the effects of bacterial infection, particularly for CDT intoxication. Here, we describe the evidence
that rapamycin reduces CDT effects by the involvement of membrane CD317/tetherin. Furthermore,
RM deeply delays the proliferation of intoxicated U937 cells and rescues them from apoptosis,
redirecting the lysosomal compartment and their positioning. Finally RM stimulates ER-remodeling,
concomitantly to the impairment of the usual progression of apoptosis and proliferation, with all
events induced by the presence of lysates containing CDT.
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2. Results
To investigate the efficacy of the CDT lysates isolated from the C. jejuni wild-type and mutant
strains in U937 cells, cytometric and confocal analyses were conducted. In the first part of the work,
we report specific results able to highlight CDT activity and to underline cell processes subsequently
modified by rapamycin. In the second and wider part of the article, RM mechanistic effects on
Campylobacter jejuni-lysate-infected U937 cells were evaluated, pointing out the processes and cellular
compartments involved.
Although the mTOR inhibitor rapamycin does not exert the complete inhibition of mTORC1
downstream targets [50], we adopted this drug, because it is a macrocyclic triene antibiotic that is
produced by fermentation of Streptomyces hygroscopicus. It is commercially available and the United
States (US) Food and Drug Administration (FDA) approved its employment in the United States.
It is used alone or in combination with other drugs in cancer [51], autoimmune diseases [52] and,
recently, [53] in bacterial infections.
2.1. Morphological Features, Cell Death, Absolute Count, and Evaluation of Cellular Division
As previously observed in monocytes, morphologic appearance was studied by microscopic and
cytometric investigations. Also in U937 cells, C. jejuni wild-type lysate caused the typical CDT-dependent
cellular distension, compared with untreated control cells and cells treated with the mutant strain lysate.
Different sub-populations are visible on the basis of cellular scatter characteristics: we can distinguish
normo-sized cells (red events—P1), distended/enlarged cells (pink events—P2), shrunken cells (blue
events—P3) (Figure 1A), since one of the main effects of CDT is indeed cell distension/enlargement.
Trypan blue viability test and absolute counting beads were applied, revealing that the wild-type
strain caused a reduction in cell number in U937 cells (as well as for monocytes and HeLa cells [45,54]).
In addition, Annexin V–propidium iodide (AnxV-PI) double staining revealed that AnxV-PI positive
cells, which represent the apoptotic cells, were particularly present in U937 cells preincubated with the
C. jejuni ATCC 33291 lysate (Figure 1B,C).
As shown in (Figure 1D–H), efficiency of CDT in G2-M blocking was investigated by means of
carboxyfluoresceinsuccinimidyl ester (CFSE), a fluorescent dye that can measure cell proliferation
using flow cytometry. Results at 48 h showed that the C. jejuni ATCC 33291 lysate exerted maximally
this blocking-effect, showing percentages of undivided cells higher than cells treated with the lysate
from the mutant strain. Moreover, via CFSE fluorescence cytometric evaluation, the efficiency of
CDT in G2-M blocking was calculated at 72 h (Figure 1F–H)). Bar graphs regarding the first, second,
and third division indicated that the typical CDT effect on DNA not only persisted after 72 h from
lysate administration, but also became more evident, particularly for the C. jejuni ATCC 33291 lysate.
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Figure 1. Evaluation of cell death induced by lysates and verification of the efficiency of the toxin,
verified only in the ATCC33291-treated cells (A) U937 were split into different sub-populations
depending on the morphologic parameters: blue gate shows dead cells, pink gate shows distended
cells, and red gate shows viable cells. Total cells were the summary of red, pink, and blue gates.
Black represents debris which were excluded for the analysis. Dot plots in the picture show control
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(CTRL) untreated cells and cells treated with the C. jejuni ATCC 33291 lysate for 72 h. (B) Density plot
of propidium iodide (PI) vs. Annexin V (AnxV) of all experimental conditions. Q1 shows PI positive
cells, Q4 shows AnxV positive cells, Q2 shows AnxV-PI positive cells, Q3 shows AnxV-PI negative cells
and debris. (C) Statistical histograms of the percentage of AnxV-PI positive cells calculated after 72 h
from lysate administration in total cells. Each value is expressed as a percentage ± SD (results from
n ≥ 3 independent experiments). Asterisks denote a statistically significant difference (*** = p < 0.001)
between strains. Statistical histograms related to CFSE dye dilution assay used to determine the number
of divisions a given CFSE-labeled cell has undergone. (D) Statistical histogram of undivided cells
calculated via CFSE staining at 48 h. (E) Statistical histogram of dividing cells calculated in cytometry
via CFSE staining at 48 h. (F–H) Statistical histogram of cells in 1st, 2nd and 3rd division, at 72 h. Each
value is expressed as a mean ± SD (results from n ≥ 3 independent experiments). Asterisks denote a
statistically significant difference (* = p < 0.05, ** = p < 0.01, *** = p < 0.001) between strains.
2.2. ER Stress Evaluation
The ER is a critical stress-responsive organelle, where ER stress leads to the production of nuclear
C/EBP-homologous protein (CHOP), which has been implicated as a key mediator of ER stress-mediated
cell damage [55]. Unfolded protein response (UPR) is indeed a stress response pathway that promotes
the inflammatory response and plays a critical role in a wide range of cellular pathologies [56]. At first,
in order to investigate ER stress induced by lysates, U937 cells were stained with ER-Tracker (a live cell
stain highly selective for the ER) and analyzed in both cytometry and confocal microscopy. The results
reported in Figure 2A–C show that ER stress occurred in U937 cells particularly after 24 h. In addition,
having observed significant variations in ER Tracker MFI (Mean Fluorescence Intensity) at 24 h in cells
preincubated with the C. jejuni ATCC 33291 lysate, CHOP gene expression was quantitated at the same
time. As shown in Figure 2C, CHOP expression was significantly induced after 24 h treatment with
C. jejuni ATCC 33291 lysate.
2.3. Prb Detection
Retinoblastoma protein (pRB) has been shown to regulate glucose tolerance, mitogenesis,
glutathione synthesis, and the expression of genes involved in central carbon metabolism [57].
Several studies have indicated that pRb proteins exhibit tumor suppressor activities, and play a central
role in cell cycle regulation [58]. In fact, recent data [44] have shown that this protein, although owing
to its role in the G1/S cell cycle checkpoint, participates in many other cellular functions, including,
counterintuitively, negative regulation of apoptosis.
Changes in pRb (Figure 2D-E) highlight a significant increase between ATCC and mutant-treated
cells. Our data show an overexpression of pRb in cells after an incubation of 72 h with the wild-type
lysate, compared with the control and the mutant. Confocal analyses focused on the nuclear localization
of pRb, well evident after the ATCC 33291 lysate administration. We can consider a pRB-dependent G2
arrest (induced by toxins), accordingly to data from the literature [59]. This process has features of
noncanonical cell cycle blocker function, normally explicited in the G1/S cell cycle checkpoint, able to
reduce proliferation and apoptosis in C. jejuni infected cells [45].
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(A) Single confocal optical secti s f I of untreated cells and treated U937 at 24 h. Bars:
10 µM. (B) Statistical ist r c er FI at 24 h, quantitated by flow cytometry. Each value
was converted to arbitrary units (A.U.), se ting the control s . c l
± SD (re ults from n ≥ 3 independent exp riments). (C) Evaluation of C/EBP-homolog us protein
(CHOP) expression in U937 cells after 24 h from lysate administration. Welch’s unpair d t test revealed:
** p = 0.009 for CTRL vs. ATCC 33291. Evid nce of pRb modulation by fl cytometry and confocal
microscopy. (D) Statistical i i tracel ular content in U937 cells at 72 h. Each value was
converted to arbitrary units ( . .), tr l as 1. Each value was expressed as a mean ± SD
(results from n ≥ 3 independent experiments). The asterisk denotes a statistica ly significant diff
(* = p < 0.05) b tween strains. (E) Single confocal optical secti ns of pRb MFI of un reat d cells and
U937 cells preincubated with the C. jejuni ATCC 33291 lysate for 72 h. Bars: 10 µM.
2.4. Rapamycin Inhibition of MTORC1 Signalling Reduces CDT-Induced Distension, Cell Death
and Proliferation
RM administration can reduce or eliminate important, CDT-induced effects, such as cell size
enlargement, degree of apoptosis, and cell cycle perturbation (Figure 3). In particular, this last effect
is due to the deep impact of RM in cell growth: It is known [60] that growth is decreased, and also
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our results on cell count underlined this evidence (Figure 3A), accordingly to pRb data (Figure 4D)
Furthermore, RM administration leads to a decrease in apoptotic events, as stated by PI uptake results
(Figure 3B). Intriguingly, since mTOR regulation of cell growth and cell size is complex, involving tight
regulation of both anabolic and catabolic processes, RM appears to limit the cell enlargement induced
by CDT (Figure 3C,D). To exclude that the prevalence of catabolic over anabolic pathways represents
the main cause of cell size reduction, we performed the same analytic approach on RM+ and RM-
control cells (S1-I): at 24 h and 48 h, RM+ cells demonstrated a slight and not relevant cell size decrease,
if compared with RM- control cells. Of note, at the 72-h time point, RM-treated control cells highlighted
a moderate increase in cellular dimension (Figure S1-I), whereas in ATCC 33291-treated cells, RM still
continued to limit CDT-induced cell distension. (Figure 3C,D). The trend of cell distension/enlargement,
evaluated on the basis of the forward light scatter (FSC) cytometric parameter, was also checked by
measuring cell size in several single confocal optical sections (Figure S1-II, III). The above-mentioned
effects are evident in ATCC 33291 lysate-treated cells, showing that RM specifically antagonizes the
efficient CDT produced by this strain.
Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 7 of 22 
 
due to the deep impact of RM in cell growth: It is known [60] that growth is decreased, and also our 
results on cell count underlined this evidence (Figure 3A), accordingly to pRb data (Figure 4D) 
Furthermore, RM administration leads to a decrease in apoptotic events, as stated by PI uptake results 
(Figure 3B). Intriguingly, since mTOR regulation of cell growth and cell size is complex, involving tight 
regulation of both anabolic and catabolic processes, RM appears to limit the cell enlargement induced 
by CDT (Figure 3C,D). To exclude that the prevalence of catabolic over anabolic pathways represents 
the main cause of cell size reduction, we performed the same analytic approach on RM+ and RM- 
control cells (S1-I): at 24 h and 48 h, RM+ cells demonstrated a slight and not relevant cell size decrease, 
if compared with RM- control cells. Of note, at the 72-h time point, RM-treated control cells highlighted 
a moderate increase in cellular dimension (Figure S1-I), whereas in ATCC 33291-treated cells, RM still 
continued to limit CDT-induced cell distension. (Figure 3C,D). The trend of cell 
distension/enlargement, evaluated on the basis of the forward light scatter (FSC) cytometric parameter, 
was also checked by measuring cell size in several single confocal optical sections (Figure S1-II, III). The 
above-mentioned effects are evident in ATCC 33291 lysate-treated cells, showing that RM specifically 
antagonizes the efficient CDT produced by this strain. 
 
Figure 3. Evaluation of cell count, cell death, and cell size induced by lysates and rapamycin (RM) 
administration (A) Absolute count calculated after 72 h from lysate administration in total cells. Each 
value is expressed as an absolute number ± SD/mL (results from n ≥ 3 independent experiments). (B) 
Trends of percentage of AnxV-PI positive cells calculated from T0 to 72 h from lysate administration, 
with (RM+) or without RM (RM-). Each value is expressed as a percentage ± SD (results from n ≥ 3 
independent experiments). Asterisks denote a statistically significant difference (***= p < 0.001) between 
strains. (C) Trends of forward light scatter (FSC) values for each treatment during the time course from 
the starting time point (T0) to 72 h. Each value is expressed as a mean ± SD (results from n ≥ 3 
independent experiments). Asterisks denote a statistically significant difference (* = p < 0.05) between 
strains. (D) Dot plots of scatter characteristics (FSC vs. side scatter (SSC)) of U937 control cells (CTRL) 
and C. jejuni ATCC 33291 U937 treated cells with (ATCC 33291 RM+) or without (ATCC 33291) 
rapamycin at 72 h. Cellular distension (events in blue) is well appreciable for C. jejuni ATCC 33291 U937 
treated cells; rapamycin, on the other hand, reduces the amount of distended cells. The gates are drawn 
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2.5. Rapamycin Stimulates ER-Remodeling, Increases Lysosome Number, Modifies Their Distribution, 
Decreasing Prb and Bcl-2 Content 
i r . l ti f cell c t, cell death, and cell size induced by lysates and rapamycin (RM)
i istr ti ( ) Absolute count calculated after 72 h from lysate administration in total cells.
E ch value is xpressed as an absolute number ± SD/mL (results from n ≥ 3 independent experiments).
(B) Trends of percentage of AnxV-PI positive cells calculated from T0 t fro lysate administration,
it ( ) r it t ( -). l is express as a percentage ± SD (results from n ≥ 3
i t ri e ts). t i e ote a statistically significant difference (** = p < 0.0 1) betwe n
t i . (C) Trends of forward light scatter (FSC) values for each treatment during the time cou se
from the starting time point (T0) to 72 h. E ch value is expres ed as mean ± SD (results from
n ≥ 3 independent experimen s). A terisks deno e a statist cally significant difference (* = p < 0.05)
between strains. (D) Dot plots of scatter characteristics (FSC vs. side scatter (SSC)) of U937 control cells
(CTRL) and C. jejuni ATCC 332 1 U937 treated cells with (ATCC 33291 RM+) or it t ( T 3 291)
t 72 h. Cellular distension (events in blue) is well appreciable for C. jejuni ATCC 332 1
U937 treated cells; rapamycin, on the other hand, reduces the amount of distended cells. The gates re
d awn ar nd roughly the same areas of Figure 1.
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ER tracker and LTDR fluorescence by quantitative analysis (flow cytometry). (B,C) For investigated
parameters, ER (by ER Tracker staining) and lysosomes (by LTDR staining), a comparison between RM-
and RM+ values was carried out for each experimental condition at 72 h. The pRb and bcl-2 expression
modulated by lysates (light blue) and lysates + RM (dark blue). (D) Statistical histograms of MFI of
pRb were calculated after 72 h from lysate administration in distended cells with and without RM. Each
value was converted to arbitrary units (A.U.), setting the control as 100. (E) Statistical histograms of
MFI of bcl-2 was calculated after 72 h from lysate administration in distended cells with and without
RM. Each value is expressed as a mean ± SD (results from n ≥ 3 independent experiments). Asterisks
denote a statistically significant difference (* = p < 0.05) between strains.
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2.5. Rapamycin Stimulates ER-Remodeling, Increases Lysosome Number, Modifies Their Distribution,
Decreasing Prb and Bcl-2 Content
Once established the main parameters and cellular pathways in which we expected to highlight
a marked role of RM, we evaluated the activation of autophagy by mTOR inhibition, investigating
the effects of RM in U937 cells, uninfected or infected with the respective lysates. As shown in
Figure 4, significant differences were reported between uninfected and infected cells (by lysates) and
untreated and treated cells (by RM). ER stress was significantly demonstrated for the wild-type strain,
although mutant treated cells also showed a certain increase of ER tracker MFI and CHOP increase
(Figure 2A–C). The additional enlargement that we observed for ER tubules and sheets, in ATCC 33291
lysate-treated cells, may be due to the CDT-dependant rearrangement of the cell size [61] (Figure 4A).
Although ER stress and autophagy can function independently, mounting evidence indicates that
autophagy is interrelated to the ER at many levels. Cytometric data (Figure 4B) demonstrated that
RM, in ATCC 33291 treated cells, significantly and deeply increase lysosomal compartment (traced
by Lysotracker Deep Red-LTDR, a fluorescent dye for labelling and tracking acidic organelles in live
cells): this event is certainly due to the combination of CDT plus RM, as the inhibitor of mTOR does
not increase as much as lysosomes, neither in the control or in the mutant treated cells. Contemporary
RM administration decreases ER-tracker fluorescence (Figure 4C), particularly and significantly in
ATCC33291-treated cells.
This behavior is accompanied by a decrease in both pRb and bcl2 (Figure 4D,E). In fact,
RM pretreatment reduces pRb intracellular content in ATCC 33291 lysate-treated cells: this finding is
consistent with the limitation of some effects exploited by CDTs, i.e., cell cycle blocking, enlargement
of cell size and autophagosome/autophagolysosome induction. In fact, Rb protein is upregulated by
wild-type lysate and subsequently reduced by RM pretreatment. A decrease of the anti-apoptotic
protein, Bcl-2, is usually associated with amplified apoptosis; however, as demonstrated in the previous
paragraph, RM reduces PI+ events, induced by CDT. Coupling these findings, we identified that in
U937 cells, the induction of cell death by CDT is, at least in part, bcl-2-independant and that RM leaves
the cells still prone to apoptotic triggers.
Confocal analyses were applied not only to confirm the flow cytometric quantification of ER and
lysosomal network, but also to underline a possible co-localization of the two compartments, suggested
by the flow cytometric data. ER-remodeling behavior is focused by the orange merged-area and
quantitated by Pearson’s coefficient. (Figure 5A,B). RM induces a concomitant increase of LTDR MFI and
the decrease of ER-tracker MFI was quantitatively calculated by FCM coupled to Pearson’s coefficient
evaluated by CM (Figure 5B). Furthermore, by means of TMRE (a potentiometric probe that can be
used for direct measurement of the mitochondria membrane potential ∆Ψm) [45], we evaluated the
RM preservation of ∆Ψm (Figure 5D,E) and concomitant increase in TMRE–ER-tracker co-localization
(Figure 5D,F). This increase in ER–mitochondria proximity [62] and in TMRE fluorescence suggests
that RM can modulate both mitochondrial bioenergetics and ER–mitochondria contacts. We want to
highlight how the quantitative cytometric data help to interpret the co-localization frameworks: in fact,
the increase of co-localization for lysosomes and ER happens in parallel to a significant and relevant
decrease of ER-tracker fluorescence (Figure 4C) (attesting a decrease in ER cisternae and tubules), and a
strong increase in lysosome–LTDR fluorescence (for ATCC 33291 lysate-treated cells only).
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Figure 5. Confocal analyses: ER morhology and extension and its relationship with lysosomes.
(A) Single confocal optical sections of ER Tracker (in green) and LTDR (in red) of ATCC33291 lysate
treated U937 cells and U937 cells preincubated with lysate and treated by RM, after 72 h. Co-localization
is shown in yellow-orange and white arrows indicate the positioning of lysosomes, from a perinuclear
area (ATCC 33291 RM-) to a peripheral distribution (ATCC 33291 RM+). Bars: 10 µM. In (B), Pearson’s
coefficient, able to quantitate co-localization, specifically induced by RM in ATCC 33291 lysate treated
cells. Asterisks denote a statistically significant difference (* = p < 0.05) between strains. (C) Lysosome
distance from surface calculated by ImageJ. Calculation performed on 30 cells for each experiment (n = 3).
Only lysosomes with a puncta and definite morphology were counted, from a minimum of 10/cell to a
maximum of 30/cell. Mitochondria membrane potential and ER–mitochondria interactions. Asterisks
denote a statistically significant difference (*** = p < 0.001) between strains. (D) Single confocal optical
sections of ER Tracker (in green) and TMRE (in red) of ATCC33291 lysate treated U937 cells and U937
cells preincubated with lysate and treated by RM, after 72 h. Red fluorescence from mitochondria and
their puncta are clearly increased in RM+ cells. Bars: 10 µM. (E) TMRE MFI values of RM- and RM+
lysate-treated U937 cells. Asterisks denote a statistically significant difference (*** = p < 0.001) between
strains. (F) Pearson’s coefficient, able to quantitate TMRE/ER-tracker co-localization, specifically
induced by RM in ATCC 33291 lysate treated cells. Total extracellular vesicles (EVs) and EVs from
lysosome exocytosis. Asterisks denote a statistically significant difference (* = p < 0.05) between strains.
(G) Flow cytometric quantitation of CD107a + EVs with (RM ATCC 33291) or without (ATCC 33291).
Asterisks denote a statistically significant difference (* = p < 0.05) between strains. (H) Flow cytometric
quantitation of lipid dye + EVs with (RM ATCC 33291) or without (ATCC 33291).
In Figure 5A, we can observe a diverse positioning of lysosomes, moving from a perinuclear
area to a peripheral distribution (arrows). This is an intriguing effect because lysosomal positioning
influences mTOR activity, autophagosome biogenesis and autophagosome–lysosome fusion [63].
The availability of lysosomes at the perinuclear region could control the rate of autophagosomal
degradation. The observed peripheral lysosome distribution (Figure 5C), induced by RM, is optimal
for budding and release via lysosomal exocytosis, as previously demonstrated [45]. Autophagic flux
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and exosome release are two connected processes that cause loss of cellular membrane and protein
content. Figure 5G,H highlights extracellular vesicle count in ATCC33291 lysate-treated cells and
RM-treated counterparts. We can observe a moderate and non-significant increase (15%) in lipid dye
positive vesicles of RM ATCC samples in respect of ATCC samples, whereas this increase becomes
more evident (25%) and significant for CD107a+ vesicles, in agreement with the peripheral dispersion
of lysosomes. These data underline that RM interferes specifically in lysosomal exocytosis and not
mainly on multivesicular body (MVB) formation, budding, and release.
2.6. Evaluation of Membrane Microdomains
CD317/tetherin is an organizer of membrane microdomains [64]. CD317/tetherin is an antigen
localized within lipid rafts on the cell surface, in the TGN, and/or within recycling endosomes [17].
The different positioning of lysosomes and the extracellular vesicle release, together with its involvement
during infections, prompted us to investigate the expression and the distribution of CD317 in our
experimental model. As showed in Figure 6C,D, in infected U937, we found an important increase in
CD317 expression after 48 h of treatment, whereas RM significantly prevented this effect. Confocal
analyses confirm the cytometric data highlighting also a redistribution of CD317 on the cell surface.
We observed the formation of a large number of CD317 clusters, in particular in ATCC 33291 treated
samples (Figure 6C), whereas in the control condition, this surface antigen appeared to spread on the
cell membrane. A similar phenomenon was also observed by other researchers that demonstrated
that HIV-1 viral proteins bring to the reorganization of plasma membrane microdomains inducing
the coalescence of lipid rafts and tetraspanin-enriched microdomains [65]. As evident in Figure 6C,
RM pre-treatment avoided CD317 clusterization and coalescence, appearing similar to the control
condition, also in the presence of lysates. It is clear that RM, by modifying the levels and distribution
of CD317, plays a role in the organization of lipids in the plasma membrane and in the distribution of
proteins that are confined to lipid rafts [66].
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analyses, respectively. (A) Single confocal optical sections of CD317 of untreated U937 cells (CTRL) and
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U937 cells after 72 h of treatment by lysates, with and without RM. Bars: 10 µM. (B) A comparison
between RM- and RM+ ATCC33291 lysate (CDT active)-treated cells: magenta stain represents
ER-tracker fluorescence, added to better visualize CD317 distribution and to resemble the ER decrease
induced by RM. Bars: 10 µM (C) Statistical histograms of CD317 MFI were calculated after 72 h from
lysate administration in cells with and without RM. Each value was converted to arbitrary units (A.U.),
setting the control as 100. Each value is expressed as a mean ± SD (results from n ≥ 3 independent
experiments). Asterisks denote a statistically significant difference (* = p < 0.05) between strains.
3. Discussion
In this paper, we studied the effects of RM in C. jejuni CDT containing lysate-treated U937 cells.
As it was already demonstrated [45,54], C. jejuni lysates were able to induce morphologic changes,
cell cycle arrest, therefore a reduction in cell number, and apoptosis in different cell models. Here,
we demonstrate, for the first time, the powerful action of RM on C. jejuni lysate-treated U937 cells,
particularly on the mechanisms of CDT activity.
Adopting U937 as a cellular model [47–49], we firstly tested CDT activity on U937 cells, examining
apoptosis, cell cycle blocking, ER stress, and pRb expression. Indeed, lysosome network involvement
and ER-remodeling induction were found as two subcellular processes triggered by RM in saving cells
from the action of CDT and, more generally, from the effects of lysates.
At the center of the regulation of mTORC1 signaling is the lysosome, and lysosome distribution
influences mTORC1 activity. Intriguingly, the bulk of lysosomes, early and late endosomes, locates
quiescently in the perinuclear region of the cell [67–72], poised toward the cell’s periphery, as it is shown.
Our data display a moderate rise in the lysosome network, primed by lysates, and significantly peaked
by the addition of RM. This behavior is particularly evident in cells preincubated with the C. jejuni
ATCC 332921 lysate, with an active CDT. These findings demonstrate that RM specifically counteracts
CDT activity. Contemporarily, after 72 h of treatment, U937 cells respond to stimuli by activating the
expansion of the acidic compartment, increasing ER–lysosome contacts and decreasing the ER volume:
a scenario strongly suggesting ER-phagy. Late endosomes and lysosomes also make extensive contact
with the ER, and numerous studies implicate ER-endolysosomal cross-talk in organelle reshaping and
migration [73]. The ER-remodeling and ER-phagy events are selectively activated and they possess
the potential to rebalance the ER network and, in our data, might also impact the function of other
organelles. It is known that, under basal conditions, ER-phagy occurs constantly at a low level to
maintain ER homeostasis [74] and also plays a prominent role in the innate defence against viral and
bacterial infections [75,76]. In fact, after the lysate administration, we observed ER stress and ER
expansion in cells, and RM, clearly triggering a lysosome increase, strengthening of acidic vacuoles,
and ER-remodeling (with features of ER-phagy), represents a powerful treatment to minimize the
pathogen attack [77], and it is able to re-establish the pre-stress ER volume, content, and activity [78].
The ER is the only intracellular organelle covering every corner of the cytosol, it has been shown to
participate in various functional contacts with other membranous compartments, mediating exchange
of metabolites and controlling transport and fusion processes [68,79].
Our findings demonstrate that ER-remodeling (with a key role in the maintenance of ER
homeostasis) participates in the cell survival and functional recovery induced by RM. Bravo-Sagua and
coworkers [63] showed that ER stress, during its early stage, increases the ER–mitochondria contacts,
thus leading to an adaptive increase in mitochondrial energetics. This appears to be a generic response
to acute stress, as we similarly observed such changes upon inhibition of the nutrient-sensing kinase
mammalian target of rapamycin complex 1 (mTORC1) [80]. In fact, RM enables lysate treated cells
to maintain a high mitochondrial membrane potential, accordingly to the decrease of the apoptotic
process. Furthermore, RM seems to increase the ER–mitochondria proximity and higher mitochondrial
membrane potential, as it appears from FCM and CM analyses of TMRE/ER-tracker labelled samples.
We detected an increase in the pRb intracellular content, significantly induced by the wild-type
strain and partly reverted by RM administration. We found for the first time that this drug is able to
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partially avoid or delay specific sub-lethal effects, most of these linked to CDT action, able to infer in
U937 cells autophagic and ER stress. The pRb decrease (as well as bcl-2 drop) characterizes a cellular
status prone to apoptosis. Such effect, together with the downregulation of CD317/tetherin, picked by
lysates in the cell surface, represents part of the mechanistic aspects of the results shown in Figure 3.
pRb has been reported to cause growth arrest and inhibit apoptosis [81]. Upregulation of pRb by
the C. jejuni wild-type strain might represent a helpful expedient that this bacterium might activate to
persist in host cells and to contrast with the programmed cell death. Noteworthy RM addition decreases
nuclear pRb content. Interestingly, the recent literature on pRb indicates that loss of pRb function
enhances the efficacy of several types of anticancer agents, including tamoxifen, microtubule-interfering
agents, and DNA-damaging agents [82]. It has been reported that pRb and lysosomes are interconnected
during senescence [83]. The lysosome also extensively communicates with other cellular structures
by exchanging content and information and by establishing membrane contact sites. It is now clear
that lysosome positioning is a dynamically regulated process and a crucial determinant of lysosomal
function. Our results show that RM strongly induces a redirection of lysosomes, from a juxta-nuclear
position towards the periphery. Lysosomal positioning is intimately associated with mTORC1 activity
and nutrient levels. For example, mTORC1 activation under nutrient-rich conditions causes scattering
of lysosomes to the periphery [84,85]. Furthermore, we showed that the RM-induced lysosome
redistribution is in connection with vesicle release. The directionality of vesicle transport is regulated
also by ER-lysosome contact sites. Currently, contact sites between the ER and endolysosomes are
emerging as potent regulatory hubs for vesicle transport [86,87], fusion [88], and fission [89] events.
The process of vesicle release in our research is limited to CD107a+ extracellular vesicles (EVs),
resembling lysosomal exocytosis and clearly increased by RM.
CD317/tetherin (i.e., BST2 or HM1.24 antigen) is an interferon inducible membrane protein present
in regions of the lipid bilayer enriched in sphingolipids and cholesterol (often termed lipid rafts).
It has been implicated in an eclectic mix of cellular processes including, most notably, the retention of
fully formed viral particles at the surface of cells infected with HIV and other enveloped viruses [90].
Edgar and coworkers [20] demonstrated that reduction of tetherin strongly reduces the number of
exosomes associated with the plasma membrane with a concomitant increase in exosomes released
into the medium. In agreement with these findings, we found an increase of extracellular vesicles in
the medium of RM+ ATCC 33291-treated cells, together with a decreased amount of CD317 in the
plasma membrane.
In fact, in our model, rapamycin pre-treatment avoids CD317 clusterization and coalescence,
previouly induced by lysates, particularly by CDT. RM not only decreases CD317 expression but
impacts on its distribution: this molecule displays antiviral (and antibacterial) functions and it is
involved in disease manifestation [91]. Therefore, modulating CD317 expression and/or activity has
the potential to influence the course of disease.
In summary, C. jejuni cytolethal distending toxin impairs apoptosis and lysosomal routes with
evidence of ER stress; RM modifies this cellular response to CDT exposition, increasing and redirecting
lysosomes, in order to unlock the later stages of lysosomal exocytosis, increasing the release of
extracellular vesicles, and the clear reduction and re-assembly of CD317/tetherin.
This research, although with the known limitations of the cellular “in vitro” model, opens up the
possibility to use RM as a drug to minimize the risk of the onset of sequelae such as the Guillain–Barré
syndrome, in case of massive and important infections by C. jejuni. Further aspects are under
investigation, to deeply monitor the pathways identified here in the RM control of U937 C jejuni
lysate intoxication.
A deeper understanding of the modulations and interconnection between these physiological
processes, especially under pathological conditions, will be of great importance and may shed light on
developing new strategies in treating C. jejuni infections.
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4. Materials and Methods
4.1. Cell Culture
U937 (human myelomonocytic cell line) cells (Sigma-Aldrich, St Louis, MO, USA) were grown
in RPMI 1640 supplemented with 10% heat-inactivated fetal bovine serum (FBS), 2 mM glutamine,
and 1% antibiotics, and was maintained at 37 ◦C in humidified air with 5% CO2.
4.2. Growth Conditions of Bacterial Strains and Cell Lysate Preparation
C. jejuni ATCC 33291 and C. jejuni 11168H cdtA mutants were grown at 37b ◦C in a microaerobic
chamber (Don Whitley Scientific, Shipley, United Kingdom) containing 85% N2, 10% CO2, and 5% O2,
either on blood agar (BA) plates containing Columbia agar base (Oxoid, Basingstoke, United Kingdom)
supplemented with 7% (v/v) horse blood (TCS Microbiology, United Kingdom) and Campylobacter
Selective Supplement (Oxoid), or in Brucella broth (Oxoid) with shaking at 75 rpm. C. jejuni strains
were grown on BA plates for 24 h prior to use in all assays, unless otherwise stated.
C. jejuni strains were grown in 50 mL Brucella broth (Oxoid) at 37 ◦C in a shaking incubator
under microaerophilic condition for 48 h. The bacterial suspensions were centrifuged at 4000 rpm for
10 min and the pellets were resuspended in 20 mL of Dulbecco’s modified eagle medium (D-MEM)
(Sigma-Aldrich, St Louis, MO, USA). Then, bacterial suspensions were adjusted spectrophotometrically
to approximately 108 bacteria/mL and lysed by sonication (2 × 30 s bursts with 30 s intervals between
each burst) by using a sonicator (Sonifier 450, Branson, Danbury, CT, USA). Cell debris and un-lysed
bacterial cells were then removed by centrifugation at 4000 rpm for 10 min. Aliquots of each lysate
were sterilized by a 0.22-µm membrane filter (Millipore, Milano, Italy) and stored at −20 ◦C before
use [68].
4.3. Pre-Treatment of U937 Cells with Rapamycin
RM is an efficient pharmacological inhibitor of mTOR (mammalian target of rapamycin), which
is able to induce autophagy in mammal cells [9]; mTOR is a complex composed of two entities,
mTORC1 (mTOR complex 1) and mTORC2 (mTOR complex 2); mTORC1 is a downstream target of
PI3K (phosphoinositide 3-kinase) and is sensitive to the RM [92]; mTOR plays an important role in
cell growth and proliferation [93] and its activation was recently associated to intestinal inflammation
induced by C. jejuni [94]. U937 cells were pre-treated with RM 100 nM for 2 h before the treatment
with lysates.
4.4. Pre-Treatment of U937 Cells With C. jejuni Lysates
U937 cells were incubated for 6, 12, 24, 48, and 72 h with 2 mL of media enriched with C. jejuni
cell lysates (1:100 dilution) from ATCC 33291 and 11168H cdtA mutant strains previously prepared.
Treated cells were analyzed by means of flow cytometry and confocal microscopy to evaluate different
cellular parameters. For the negative control, cells were incubated with media only.
4.5. Detection of Cytotoxin Activity in C. jejuni Lysates
U937 cells were seeded into 24-well tissue culture plates at a density of 2.6 × 105 cells per well for
2 h prior to the addition of the lysates diluted at 1:5, 1:10, 1:50, 1:100, and 1:500, respectively. The cultures
were incubated at 37 ◦C in 5% CO2 atmosphere and examined microscopically at 24-hour intervals for
4 days to evaluate morphological changes. The best acting dilution was the 1:100 which was chosen
for all subsequent evaluations. All strains were tested in at least three independent experiments.
4.6. Morphological Feature Evaluation
To evaluate changes in cell morphology and size, both cytometry and confocal microscopy were
used. In flow cytometry, populations that differed in size and morphology were distinguished by using
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their physical characteristics: forward scatter (FSC, cell size) and side scatter (SSC, cell granularity).
Although a quantitative analysis was carried out by flow cytometry, a parallel microscopic evaluation
of cell dimension was performed.
4.7. Flow Cytometry (FCM) and Confocal Microscopy (CM) Stainings
4.7.1. Flow Cytometric Detection of Cell Death and Flow Cytometric Absolute Count
Cell death features were evaluated using supravital propidium iodide (PI) (Sigma-Aldrich) that
is capable of binding and labeling DNA. No permeabilized cells were incubated 30 min in the dark
with 50 µg/mL PI. Cells were washed with PBS and then analyzed by flow cytometry. Apoptotic and
necrotic cells were detected as PIdim and PIbright clusters, respectively.
To investigate programmed cell death features (early and late apoptotic, as well as necrotic cells),
we also used a double staining FITC-conjugated Annexin V-PI (AnxV-PI). AnxV allows to detect
phosphatidylserines exposed on the outer cell membrane following caspase activation. AnxV-PI
staining was carried out according to the manufacturer’s instructions (Immunostep, Spain). Absolute
cell counting was performed by using Dako CytoCountTM beads (Thermo Fisher Scientific, Waltham,
MA, USA). 200 µL of sample was carefully dispensed at the bottom of the tube and 50-µL beads were
added. Samples were acquired by using a FACSCanto II cytometer ((BD, Franklin Lakes, NJ, USA))
within 60 min. Approximately 20,000 cell events were collected. Setup and calibration procedures
were optimized for the absolute counting protocols [95].
4.7.2. Evaluation of Cellular Division by CFSE Staining
Carboxyfluoresceinsuccinimidyl ester (CFSE) is a fluorescent dye that can measure cell proliferation
using flow cytometry. CFSE was transported into the cell during incubation with mononuclear cells
binding covalently to cytoplasmic proteins, without adversely affecting cellular function. Analysis of
cell division can be determined through measuring CFSE intensity by flow cytometry: with each cell
division, the fluorescent intensity per cell division is reduced by 50 %, thus providing a readout of the
mitotic activity within a specific population of cells. U937 cells were staining with 3 µM CFSE at day 0
and then analyzed at 24, 48, and 72 h [54]. At these times, U937 treated and untreated samples were
harvested and acquired by flow cytometry.
4.7.3. Assessment of Lysosomal Involvement
To label and trace lysosomes in U937 cells, the acidotropic dye LysoTracker Deep Red (LTDR)
(Thermo Fisher Scientific, Waltham, MA, USA) was used. LysoTracker probes are fluorescent acidotropic
probes for labeling and tracking acidic organelles in live cells: it means that the amount of fluorescence
obtained from staining with LysoTracker is directly related to the volume of lysosome-related organelles
in a cell [96]. Cells were cultured at 37 ◦C and resuspended in pre-warmed (37 ◦C) medium containing
100 nM of LysoTracker (diluted in RPMI). After 45 min of incubation, red lysosomal fluorescence was
detected by flow cytometry and confocal microscopy [97].
4.7.4. Determination of Mitochondria and Mitochondrial Membrane Potential (∆Ψm)
Mitochondrial features were investigated by Tetramethylrhodamine ethyl ester perchlorate (TMRE)
(Sigma-Aldrich, St. Louis, MO, USA) is a ∆Ψm-specific stain able to selectively enter the mitochondria
depending on ∆Ψm, producing red fluorescence. TMRE 40 nM was added to the samples 15 min
before the acquisition time. The samples were analyzed by confocal microscopy and flow cytometry
using the appropriate fluorescence channel [45,98].
4.7.5. ER Stress Evaluation
ER-Tracker Green (Thermo Fisher Scientific, Waltham, MA, USA) is a live-cell stain highly selective
for the ER. This stain consists of the green-fluorescent BODIPY® FL dye and glibenclamide that bind
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to the sulphonylurea receptors of ATP-sensitive K+ channels which are prominent on the ER and have
a critical role in the ER luminal homeostasis. Indeed, ER K+ channels are involved in functions such as
protein folding, apoptosis, and Ca2+ homeostasis [99,100].
U937 were incubated with 100 nM ER-Tracker Green for 30 min at 37 ◦C and subjected to flow
cytometry and confocal analyses.
4.7.6. CD317 Expression Evaluation
To evaluate CD317 expression, fluorochrome-conjugated monoclonal antibodies were added to
50 µL of cell pellet. Mouse monoclonal anti-human antibodies Alexa Fluor® 647 anti-CD317 (129C1)
(BioLegend, San Diego, CA, USA) was added at dilutions according to the manufacturer’s instructions.
After 15 min of incubation at RT, samples were acquired by flow cytometry and/or confocal microscopy.
4.7.7. Intracellular Detection of Prb and Bcl-2 Antigens
U937 were washed in PBS for 10 min at RT, resuspended in 300 µL formaldehyde 3.7% and
incubated at 4 ◦C for 15 min; 2 mL perm/washing buffer was added and cells were centrifuged at
1200 rpm for 10 min. Pellets were resuspended in 300 µL Cytoperm reagent [101]. Monoclonal
anti-human antibodies Anti-pRb PE conjugated (clone G3-245) (BD) and anti bcl-2 FITC (clone
124) (Dako, Milan, Italy) were added to samples at concentrations according to the manufacturer’s
instructions. Cells were incubated at 4 ◦C for 30 min before being processed by flow cytometry and/or
confocal microscopy.
4.7.8. Extracellular Vesicle Detection
In order to detect microparticles in the extracellular environment, without any preparation step of
ultracentrifugation, we resuspended each sample (20 µL) in 0.22-filtered PBS 1X. We performed the
test by using a BD custom product, i.e., a kit based on an APC emitting lipophilic cationic dye that
diffuses through the plasma membranes [102]. After an incubation of 60 min to ensure the binding
of the monoclonal antibody (CD107a mAb, clone H4A3) (BioLegend, London, UK) to the specific
epitope, we proceeded with FC analyses. The flow cytometry approach consisted of acquiring samples
mixed with beads of defined size (Ø 0.5 µm, 1 µm, 5.2 µm) to obtain a size calibration of small particles
detected outside the scatter area of intact cells. Furthermore, it is important to specify that the FCS
of the complete medium was ultracentrifuged to minimize contamination by serum microvesicles.
Samples were acquired by a FACSCanto flow cytometer and a FACSDiva™ software was used to
analyze all data.
4.7.9. Cytometric Investigations
Cytometric experiments were carried out with a FACSCanto II flow cytometer (BD, Franklin,
Lakes, NJ, USA) equipped with an argon laser (Blue, Excitation 488 nm), a helium-neon laser (Red,
Excitation 633 nm), and a solid state diode laser (Violet, Ex 405 nm). Analyses were performed with
the FACSDivaTM software (BD); approximately 10,000 cell events were acquired for each sample.
4.7.10. Confocal Microscopy Analyses
Confocal microscopy analyses were applied by a Leica TCS SP5 II confocal microscope (Leica
Microsystem, Germany) with 488, 543, and 633 nm illuminations and oil-immersed objectives.
For confocal live imaging, cells were grown on MatTek glass bottom chambers (MatTek Corporation,
Bratislava, Slovak Republic). The images were further processed and analyzed in ImageJ software
(NIH, Bethesda, MD, USA).
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4.8. RNA Isolation and cDNA Synthesis
Cells were directly lysed with 700 µL of QIAzol® Lysis Reagent (Qiagen, Hilden, Germany).
Total RNA extraction was performed with the miRNeasy Mini Kit (Qiagen, Hilden, Germany)
following the manufacturer’s instructions. The extracted RNA was quantified using a NanoVue PlusTM
spectrophotometer (GE Healthcare Life Sciences, Piscataway, NJ, USA). The cDNA synthesis was
performed from 500 ng of total RNA using PrimeScriptTM RT Master Mix (Perfect Real Time) (Takara
Bio Inc. Shiga, Japan) according to the manufacturer’s instructions.
4.9. Quantitative Real-Time PCR
The expression of CHOP was monitored by qPCR using RT2 SYBR Green ROX FAST Mastermix
(Qiagen, Hilden, Germany) in a RotorGene 6000 instrument (Corbett life science, Sydney, Australia),
as described previously [103]. A non-template control was included in duplicate for each primer
pair reaction, as a negative control. To exclude the presence of non-specific products or primer
dimers, a melting curve analysis from 65 ◦C to 95 ◦C was performed at the end of each run. GUSB
(Beta-D-Glucuronidase) gene was used as reference. Relative mRNA expression was calculated using
the comparative quantitation analysis of the RotorGene 6000 software.
4.10. Statistical Analyses
Data are shown as mean (or percentage, as indicated) ± standard deviation (SD) of at least three
independent experiments. Analyses of variance (ANOVA) approaches were used to compare values
among more than two different experimental groups for data that met the normality assumption.
One-way ANOVA or two-way ANOVA were followed by a Bonferroni post-hoc test. The means of
two groups were compared by using a t test. The p values less than 0.05 were considered statistically
significant. All statistical analyses were performed using GraphPad Prism 5.0 (GraphPad software,
San Diego, CA, USA).
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